// App-Quantinova.ai

: Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype

Researchers

Presenter

  • Maria Kokosi

Principal Investigators

  • Athina Trachalaki

  • Carmel Stock

  • Jackie Donovan

  • Elisa Tsitoura

  • Vasileios Kouranos

  • Peter M George

  • Phil L Molyneaux

  • Felix Chua

  • Toby M Maher

  • Elisabetta A Renzoni

  • Nikolaos Tzanakis

  • Athol U Wells

  • Katerina Antoniou

Medical Centers

  • Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK

  • Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK

  • Department of Anaesthesia, Royal Brompton Hospital, London, United Kingdom

  • Department of Respiratory Medicine, University of Crete, Heraklion, Greece

  • Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK

Locations

  • United Kingdom

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Kerbs von Lungren 6 antigen

  • Pore forming protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved